vimarsana.com

Latest Breaking News On - Recombinant novel coronavirus vaccine - Page 10 : vimarsana.com

Pakistan reports over 5,000 COVID-19 cases, highest single day spike in 10 months

Pakistan reports over 5,000 COVID-19 cases, highest single day spike in 10 months The Ministry of National Health Services said that 83 people died in this period, taking the death toll to 14,613. Share Via Email   |  A+A A- A health care worker takes a nasal swab sample from a woman at a COVID-19 testing facility at a hospital in Karachi. (Photo| AP) By PTI ISLAMABAD: Pakistan reported more than 5,000 new coronavirus cases in the last 24 hours, the highest single day spike since June last year, the health ministry said on Friday. The Ministry of National Health Services said that 83 people died in this period, taking the death toll to 14,613.

Pakistani Company Inks Deal to Manufacture COVID-19 Vaccine

Pakistani Company Inks Deal to Manufacture COVID-19 Vaccine Joe Raedle-Getty Images North America AFP Searle’s agreement with Livzon Mapharm is linked to a vaccine that is currently in Phase II clinical trials Pakistani pharmaceutical company Searle has inked a deal with China’s Livzon Mapharm allowing it to license, manufacture, and supply a new COVID-19 vaccine in the country, according to information provided by the company to the Pakistan Stock Exchange. “Searle Company has concluded an exclusive licensing and supply agreement with Livzon Mapharm Inc. for the Recombinant Novel Coronavirus Vaccine (V-01). The licensing agreement also covers the manufacturing transition of (V-01) in Pakistan,” reads the letter submitted by the company. It said that the vaccines was in the final phases of its clinical trial, adding that early results were promising.

Searle, Chinese firm strike deal to make Covid vaccine in Pakistan - Pakistan

A local pharmaceutical company has signed a deal with a Chinese giant that allowed it to supply and produce an upcoming Covid-19 vaccine in Pakistan. Reuters/File KARACHI: A local pharmaceutical company has signed a deal with a Chinese giant that allowed it to supply and produce an upcoming Covid-19 vaccine in Pakistan, an official announcement said on Thursday. This has emerged in a letter written by M/s Searle Company Limited to the Pakistan Stock Exchange, saying it had concluded an agreement with China’s Livzon Mapharm Inc. for manufacturing novel coronavirus vaccine (V-01) in Pakistan. “Searle Company has concluded an exclusive licensing and supply agreement with Livzon Mapharm Inc. for the Recombinant Novel Coronavirus Vaccine (V-01). The licensing agreement also covers the manufacturing transition of (V-01) in Pakistan,” the company said.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.